Mechanistic and functional differentiation of tapentadol and tramadol (Q28268772)

2

0 references

Thomas Christoph

3

0 references

Gary Eichenbaum

4

0 references

Werner Englberger

5

0 references

Christopher M Flores

6

0 references

Torsten Hertrampf

7

0 references

Babette Kögel

8

0 references

Klaus Schiene

9

0 references

Wolfgang Straßburger

10

0 references

Rolf Terlinden

11

0 references

Thomas M Tzschentke

Expert Opinion on Pharmacotherapy

12

0 references

language of work or name

English

0 references

publication date

July 2012

0 references

published in

0 references

volume

13

0 references

issue

10

0 references

page(s)

1437-49

0 references

cites work

Molecular Shape and Medicinal Chemistry: A Perspective

1 reference

https://api.crossref.org/works/10.1517/14656566.2012.696097

The properties of known drugs. 1. Molecular frameworks

21 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Polypharmacology directed compound data mining: identification of promiscuous chemotypes with different activity profiles and comparison to approved drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Differential tramadol and O-desmethyl metabolite levels in brain vs. plasma of mice and rats administered tramadol hydrochloride orally

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Lessons learned from molecular scaffold analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Thermodynamics guided lead discovery and optimization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Thermodynamics of ligand binding and efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Probing the links between in vitro potency, ADMET and physicochemical parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Putting chirality to work: the strategy of chiral switches

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Facing chirality in the 21st century: Approaching the challenges in the pharmaceutical industry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Predicting polypharmacology by binding site similarity: from kinases to the protein universe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

The role of fragment-based and computational methods in polypharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Treatment of chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Designed multiple ligands. An emerging drug discovery paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Multi-target therapeutics: when the whole is greater than the sum of the parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

(-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Tramadol, M1 metabolite and enantiomer affinities for cloned human opioid receptors expressed in transfected HN9.10 neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Synergistic interaction between the two mechanisms of action of tapentadol in analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

In vitro and in vivo characterization of tapentadol metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Investigations into the drug-drug interaction potential of tapentadol in human liver microsomes and fresh human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Role of active metabolites in the use of opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Use of opioids in a Danish population-based cohort of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Opioid rotation in the management of chronic pain: where is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Extended-release Tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Systematic review of tapentadol in chronic severe pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Tapentadol extended release: in adults with chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Clinical efficacy and safety of tapentadol immediate release in the postoperative setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Undesired side effects of tapentadol in comparison to oxycodone. A meta-analysis of randomized controlled comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Pharmacologie du tramadol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

The Diversion of Ultram, Ultracet, and generic tramadol HCL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-cont

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled pha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Tapentadol and its two mechanisms of action: is there a new pharmacological class of centrally-acting analgesics on the horizon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Bad news from the brain: descending 5-HT pathways that control spinal pain processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

Preclinical and early clinical investigations related to monoaminergic pain modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.696097

10.1517/14656566.2012.696097

21 January 2018

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

2993381

2993381

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference